Tagged with MEA

UAE Globally, while there is broad stakeholder alignment on topics like clinical trials and innovation, there is real divergence in approaches to pharmacoeconomics and health technology assessment (HTA). This is perhaps in part due to the differences between systems like those in Europe where these functions are state mandates and those,…

Morocco Salim El Guermaï of leading Moroccan generics manufacturer Galenica outlines how, in the past three years, the firm played a key role in Morocco’s COVID-19 pandemic response, continued to serve Moroccan patients with essential medicines, and bolstered the country’s standing as a pharmaceutical hub for the African continent.    Our…

Morocco As North Africa cluster lead Pfizer veteran Diego Forero heads up Morocco, Tunisia, Libya, and Algeria in addition to being the country manager for Morocco. He describes the company’s 57-year presence and its local manufacturing site that produces almost 70 percent of Pfizer’s medicines marketed in Morocco as well as…

Morocco CEO Mia Lahlou-Filali walks us through Pharma 5’s commitment to “Made in Morocco” generics, an approach that has led the company to represent one third of the country’s generics market. She also explains the family-owned firm’s expansion efforts outside of Morocco that include a factory in the Ivory Coast, a…

Morocco Driss Chaoui outlines recent milestones in Afric-Phar’s over 50-year history, including the launch of its first in-house developed generic, and discusses the firm’s unique focus on orphan and rare diseases and the challenges facing the field in Morocco. He also reviews the opportunities presented by the transformation of Morocco’s regulatory…

Morocco Three years on from his last PharmaBoardroom interview, Karim Lahlou highlights the evolution of Moroccan pharma manufacturer Iberma as it expands its activities from solely in-licensing to developing and selling its own products, growing its global partnership base, and looking to penetrate international markets while leveraging the growing reputation of…

Morocco DHL’s Tina Manoukian lays out how the global logistics giant helped ensure the safe and timely distribution of medicines and vaccines during the COVID-19 pandemic, outlines the scope and scale of DHL operations in Morocco, and explains why the country is well positioned to become a distribution and logistics hub…

Morocco Wafaa Farhat Agoumi serves as DG of the Health Engineering and Project Management Graduate School (ESISMP) in Casablanca, Morocco, as well as president of the African Association for Clinical Research (AARC). Agoumi gives an overview of her current work areas of focus, the evolution of clinical research in Morocco and…

UAE Thanks to favourable regulations from the Ministry of Health and Prevention (MoHaP) which include fast-track regulatory pathways, patients in the UAE are gaining access to innovative medicines in similar time frames to their counterparts in the US and Europe, in some cases even ahead. Against this backdrop, the representatives of…

UAE As the UAE’s only gastrointestinal oncologist, Professor Humaid Al-Shamsi is well-placed to comment on the evolution of cancer care in the country, noting massive leaps forward in terms of technology, patient experience, and regulatory timelines. Looking forward, Professor Al-Shamsi calls for even greater investment into oncology R&D programs as the…

Morocco Lamia Tazi, chairwoman of the board and CEO of Sothema and VP of the Moroccan Federation of the Pharmaceutical Industry (FMIIP), walks us through the over 40-year-old family-owned Moroccan company’s heritage as well as some of its recent advances such as the launch of its own range of oncology treatments.…

Middle East & Africa Mourad Ishak began heading up Farmak’s MEA region as general manager in 2021, after almost two decades in the industry. He explains the Ukranian complex generics maker’s decision to set up an affiliate in the UAE, underlining government flexibility and agility in the region and ongoing regulatory improvements, factors which…